Volunteer: Dukas Jurenas
Dukas Jurėnas has obtained his bachelor and masters degree in molecular biology in Vilnius University, Lithuania. During his PhD in Free University of Brussels (ULB) he has characterized activity and regulation of novel acetyltransferase toxin from enterohemorrhagic E. coli O157:H7. His research is mostly focused on bacterial toxins from toxin-antitoxin systems and type VI secretion systems. Dukas uses methods from structural biology and molecular biology to modern and classical microbiology to get in depth picture of mechanisms of bacterial growth inhibition. He has attended every FEMS congress since 2011 Geneva congress and he is a member of Belgian and Lithuanian Societies for Microbiology as well as a board member of Lithuanian Biochemistry Society (FEBS member).
FEMS Yeast Research is proud to present this latest thematic issue on yeast pathogenesis and drug resistance. In the past few decades, genetics and genomics studies have uncovered traits underlying the pathogenicity and drug resistances of pathogenic yeast. However, we still have a lot to uncover about the complex mechanisms used by different species to thrive in the human host, and much to do to convert this knowledge into improved clinical treatments. This thematic issue highlights the importance of the diversity of genome-scale approaches to unravel the intricate nature of pathogenesis and drug resistance in pathogenic yeasts, bringing together a diverse range of fascinating views on antifungal drug resistance.